-
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart FailureJA Chirinos, L Zhao, Y Jia et al. -
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 StudyKosiborod M, Lam CSP, CVD-REAL Investigators and Study Group.
-
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)P Joseph, K Swedberg, DP Leong et al.
-
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) StudyIbrahim NE, Januzzi JL Jr.
-
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionShen L, Jhund PS, McMurray JJV et al.
-
Noninvasive Imaging for the Evaluation of Diastolic Function: Promises FulfilledSF Nagueh, Y Chandrashekhar.
-
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP TrialK Sharma, Stuart D. Russell and on behalf of the Osler Medical Housestaff.
-
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk FactorsM Przewlocka-Kosmala, TH Marwick, H Yang et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
